immune modulators

Merck inks $1.9B Pandion takeover to square up against Amgen, Lilly and Roche
Fierce Biotech
Thu, 02/25/21 - 10:44 am
Merck
Pandion
M&A
immune modulators
Amgen
Eli Lilly
Roche
Connect Biopharma snags $115 million in Series C to develop arsenal of immune modulators
Endpoints
Tue, 08/25/20 - 12:02 am
Connect Biopharma
Series C
immune modulators